Recent

% | $
Quotes you view appear here for quick access.

Cray Inc. Message Board

zippybalto 2 posts  |  Last Activity: Jun 15, 2016 10:52 AM Member since: Oct 14, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    USPSTF 12-Page Recommendation

    by bonevoyage914 Jun 15, 2016 10:37 AM
    zippybalto zippybalto Jun 15, 2016 10:52 AM Flag

    "[C]learly removed any hierarchy of test modalities."

    What does that mean in plain English? It means that Cologuard is no better than any other test. Or put another way, they're all special. And remember the "Incredibles" rule: if everyone is special, than nobody is."

    Even if the insurance companies get on board, it still requires a GI doc to recommend the test, which effectively delays doing a colonoscopy, something GI docs are famously loathe to do.

    ZB

  • Read the IBD story carefully. I'll save you the trouble though with the 'money quote:'

    "“The [JAMA] article states the USPSTF highly recommends colon cancer screening from age 50 to 75 but will no longer rank tests; instead, it is providing a list of acceptable ones that includes FITDNA (Cologuard),” Lavin wrote in a research note. "

    That's right: not only will Cologuard not be getting an "A" it will only be considered "acceptable" next to the gold standard of a colonoscopy. Not "recommended." Just "accepteable." Which means it will be down to EXAS's crack salesforce to convince GI docs to waste precious time on a pre-lim test like Cologuard rather than schedule and do a 'scope.' Even if this changes Cologuard's re-imbursement profile, it still takes a doc to order the test and being "acceptable" isn't going to change any doc's mind.

    So let the cash burning continue!

    ZB

CRAY
23.24-0.06(-0.26%)Aug 26 4:00 PMEDT